The Oxford Science Park

Find Out The Latest

Keep in touch with news and developments from The Oxford Science Park and its occupiers here.

You can also follow us on LinkedIn

Oxford Nanopore launches a comprehensive Hereditary Cancer Panel

08 Sep 2025

Oxford Nanopore Technologies has launched a comprehensive Hereditary Cancer Panel (HCP), which will allow users to interrogate 258 key genes associated with inherited cancer risk. The HCP provides a simple workflow with flexible batch sizes, allowing laboratories to run their own assays in-house, which can speed up time from sample-to-answer. The rich, multi-omic dataset also enables test consolidation, potentially reducing the need to run... Read more

Oxford launches major new AI vaccine research program with the Ellison Institute of Technology

01 Sep 2025

The Ellison Institute of Technology (EIT), through its strategic partnership with the University of Oxford, has received research funding of £118m to launch an ambitious new programme of vaccine research. Led by the Oxford Vaccine Group, the new initiative based in the University - CoI-AI (Correlates of Immunity-Artificial Intelligence) - will combine Oxford’s expertise in human challenge studies, immune science and vaccine development with... Read more

Moa Technology develops groundbreaking category of crop protection

27 Aug 2025

Moa Technology has announced its discovery of chemistries which could become an entirely new category of products to help farmers protect their harvests more safely, sustainably and effectively. Moa has already discovered 80 new herbicidal modes of action with its breakthrough technology platforms in the last three years, several of which are already effectively controlling tough and pervasive weeds in field trials in the US, Canada, France,... Read more

OrganOx acquired by Terumo in landmark $1.5bn deal

26 Aug 2025

The Oxford Science Park warmly congratulates OrganOx Limited on the announcement that it has signed a definitive agreement to be acquired by Terumo Corporation, a global leader in medical technology. The transaction, valued at approximately USD $1.5 billion, marks Terumo’s strategic entry into the organ transplantation-related sector and will see OrganOx become a wholly owned subsidiary. Founded in 2008 as a spinout from the University of... Read more

Santa Ono Joins the Ellison Institute of Technology as EIT Global President

19 Aug 2025

Santa Ono has been appointed to the role of President of EIT Global. Ono has a long and distinguished record of academic leadership having led both the University of British Columbia and the University of Michigan as President. He moved into academic leadership from a distinguished career in biomedical research and immunology. A key part of President Ono’s responsibilities will include working with Sir John Bell, the President of EIT Oxford, in... Read more

News